Findings from health care, pharmaceutical & life sciences orgs.
20th CEO Survey
A year of uncertainty and opportunity
These costs stem from fragmentation of resources between health care agencies; increasing requirements from declining infrastructure; an aging Canadian demographic, and a shortage of skilled labour. If the sector continues to work this way, it risks a financially unsustainable future and more potential health problems. The health care system and government must find innovative solutions to give Canadians timely access to quality care.
Health care organizations can benefit from PwC's unique insight and strategies to help address current issues that plague the sector. Our comprehensive range of experience combined with PwC's global network of health care professionals and our Health Research Institute provide clients with current surveys and publications that help with the following:
For years, registered patients in Canada have had legal access to medicinal cannabis, and if the federal government's plan remains on track for this summer, Canada will become the first G-7 country to legalize adult-use cannabis.
A maturing market brings new realities and signs point to some investor fatigue. Cannabis companies will need to differentiate to win in a crowded market. What's your strategy?
Retail pharmacies face shrinking margins in their core business and tougher competition in a shifting health industry. Yet these companies have the opportunity to redefine themselves as central players—and critical partners—in the new health economy.
Health Research Institute focuses on large-scale issues, major developments and key trends in the health industries and offers key insights and industry best practices.
Find out how mobile technology is untethering healthcare and enabling the practice of care anywhere.
Catherine Hunter
Partner, Health Care Consulting Leader, PwC Canada
Tel: +1 416 687 8465
Email
